BeyondSpring (NASDAQ:BYSI) will join the FTSE Russell 3000 Index when markets open on July 1, according to a preliminary list of additions.
Membership in the Russell 3000 Index, which remains in place for one year, means the automatic inclusion of BeyondSpring common stock in index funds designed to track stocks included in the Russell 3000 Index.
“Being added to the Russell Index is a significant accomplishment for the company and validates our growth potential,” Dr. Lan Huang, CEO of BeyondSpring, said in a statement.
“We continue to develop a robust pipeline and are advancing our lead first-in-class asset, Plinabulin, a direct anticancer agent in the treatment of non-small cell lung cancer, as well as in prevention of chemotherapy-induced neutropenia, through global Phase 3 clinical trials.”
